Topical administration of siRNA could be a new therapeutic option for the treatment of degenerative illnesses of the retina that presents processes of neovascularization[i].
PR Newswire
MADRID, May 4, 2018
PR Newswire
MADRID, May 4, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey